Literature DB >> 23531217

Study on medicinal chemistry of K203 in wistar rats and beagle dogs.

H Kalász1, P Szegi, G Jánoki, L Balogh, Z Pöstényi, K Musilek, G A Petroianu, A Siddiq, K Tekes.   

Abstract

K203 is an experimental bis-pyridinium mono-aldoxime type cholinesterase reactivator of potential use in organophosphate/ organophosphonate poisoning. Pharmacokinetics of K203 were examined in Wistar rats and beagle dogs using ion-pair HPLC. Serum and cerebrospinal fluid concentrations of K203 were determined using ion-pair reversedphase chromatography on octadecyl silica column. HPLC with ultraviolet detection was used for determination of serum concentration of K203 higher than 0.1 μg/mL while its low concentrations in cerebrospinal fluid required electrochemical detection (0.015 through 4 μg/mL range). In rats the serum levels of K203 followed zero order pharmacokinetics from 15 to 120 minutes post administration. Zero order pharmacokinetics was also observed in beagle dogs after low dose (15 μmol/kg) of K203 administration. High dose administration (250 μmol/kg) led to subsequent hindered elimination from both cerebrospinal fluid and serum.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23531217     DOI: 10.2174/0929867311320160006

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  Pharmacokinetics of Two Chlorine-Substituted Bis-Pyridinium Mono-Aldoximes with Regenerating Effect on Butyrylcholinesterase.

Authors:  Huba Kalász; Zoltán Szimrók; Gellért Karvaly; Jennifer Adeghate; Kornélia Tekes
Journal:  Molecules       Date:  2020-03-10       Impact factor: 4.411

2.  Acetylcholinesterase reactivators (HI-6, obidoxime, trimedoxime, K027, K075, K127, K203, K282): structural evaluation of human serum albumin binding and absorption kinetics.

Authors:  Filip Zemek; Jana Karasova Zdarova; Vendula Sepsova; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2013-08-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.